$71.59 2.7%
CNMD Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Conmed

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.


Conmed
Price $71.59
Target Price Sign up
Volume 488,600
Market Cap $2.27B
Year Range $61.73 - $114.23
Dividend Yield 1.17%
PE Ratio 26.26
Revenue per Employee $307,695
Earnings Date July 31 '24
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24312M140M172M20M58M0.790
Q4 '23327M145M182M33M73M1.060
Q3 '23305M137M168M16M39M0.900
Q2 '23318M147M171M14M36M0.830
Q1 '23295M140M155M1.8M35M0.660

Insider Transactions View All

Peters Stanley W III filed to sell 63 shares at $71.8.
June 17 '24
BRONSON DAVID M filed to buy 16,460 shares at $72.1.
May 14 '24
Schwarzentraub Barbara J filed to buy 1,442 shares at $69.3.
May 10 '24
Aronson Martha Goldberg filed to buy 2,000 shares at $71.
May 8 '24
Beyer Pat filed to buy 10,807 shares at $68.3.
May 2 '24

What is the Market Cap of Conmed?

The Market Cap of Conmed is $2.27B.

What is Conmed's PE Ratio?

As of today, Conmed's PE (Price to Earnings) ratio is 26.26.

How Many People Work at Conmed?

As of our latest update, Conmed employed approximately 4,100 people worldwide. However, it's important to note that Conmed's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Conmed's revenue per employee?

$307,695. To calculate Conmed's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Conmed report earnings?

Conmed will report its next earnings on July 31 '24.

What is the current stock price of Conmed?

Currently, the price of one share of Conmed stock is $71.59.

How can I analyze the CNMD stock price chart for investment decisions?

The CNMD stock price chart above provides a comprehensive visual representation of Conmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Conmed shares. Our platform offers an up-to-date CNMD stock price chart, along with technical data analysis and alternative data insights.

Does CNMD offer dividends to its shareholders?

Yes, Conmed (CNMD) offers dividends to its shareholders, with a dividend yield of 1.17%. This dividend yield represents Conmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Conmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Conmed?

Some of the similar stocks of Conmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.